Full notification fileGeneral informationNotification NumberB/IE/11/451-AMember State to which the notification was sentIrelandDate of acknowledgement from the Member State Competent Authority12/07/2011Title of the ProjectPhase 1 clinical trial to assess the safety and immunogenicity of malaria vaccineProposed period of release:01/09/2011 to 31/12/2011Name of the Institute(s) or Company(ies)Royal College of Surgeons In Ireland, ;
3. Is the same GMO release planned elsewhere in the Community?Yes: United Kingdom; Has the same GMO been notified elsewhere by the same notifier?NoGMO characterizationGMO is a:DNA VirusIdentity of the GMO:Adenovirus Ch 63-CSInformation relating to the recipient or parental organisms from wich the GMO is derived
Final reportEuropean Commission administrative informationConsent given by the Member State Competent Authority:Yes29/11/2011 00:00:00Remarks:The Irish Competent Authority under Directive 2001/18/EC issued consent to Part B notificaions B/IE/11/451-A and B/IE/11/451-B on 29 September 2011.
|Chimpanzee adenovirus 63||Mastadenovirus||not applicable||Chimpanzee adenovirus 63|